RECODE THERAPEUTICS, INC. filed a Form D with the Securities and Exchange Commission on 2025-10-23.
RECODE THERAPEUTICS, INC. filed a Form D notice of an exempt securities offering with the SEC on October 23, 2025. The filing reports $29.44M sold. Its industry group is Biotechnology. It names Shehnaaz Suliman (Executive Officer, Director), Peter Thompson (Director), Helen Kim (Director) (SEC Form D, October 23, 2025).
Is this your company?
Sell to companies like RECODE THERAPEUTICS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns RECODE THERAPEUTICS, INC.
Free to see. No signup.
More on the people and the money behind RECODE THERAPEUTICS, INC., from the filings we hold.
Biotechnology raises by companies based in California, filed in October 2025, largest first.
Get an email when RECODE THERAPEUTICS, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when RECODE THERAPEUTICS, INC. raises, hires or launches. No email unless you switch it on.
Watch RECODE THERAPEUTICS, INC. →Get the full cited report on RECODE THERAPEUTICS, INC.
What the filing shows about RECODE THERAPEUTICS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on RECODE THERAPEUTICS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives RECODE THERAPEUTICS, INC.'s address as 1140 O'Brien Drive, Menlo Park, CA 94025.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on RECODE THERAPEUTICS, INC. See pricing
RECODE THERAPEUTICS, INC. is a registered filer with the SEC (CIK 1693764) and has filed since 2023-01-27. 3 filings are on record, the latest on 2025-10-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
RECODE THERAPEUTICS, INC.'s Form D of 2025-10-23 names Shehnaaz Suliman, Peter Thompson, Helen Kim and 9 more as its officers, directors or promoters.
Its new offerings report $29.44M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Shehnaaz Suliman is named as Executive Officer and Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Peter Thompson is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Helen Kim is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Edward Hurwitz is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Rana Al-Hallaq is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Rakhshita Dhar is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Alan Colowick is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Patricia Millican is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Dean Mitchell is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Inai Park is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
Basheer Zada is named as Director on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
David Lockhart is named as Executive Officer on the Form D that RECODE THERAPEUTICS, INC. filed with the SEC on 23 October 2025, one of 12 people that filing names.
12 people named on the filing — 2 holding an executive role and 10 as directors only.
Named as of the 2025-10-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about RECODE THERAPEUTICS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on RECODE THERAPEUTICS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on RECODE THERAPEUTICS, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist RECODE THERAPEUTICS, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind RECODE THERAPEUTICS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for RECODE THERAPEUTICS, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/recode-therapeutics-inc-form-d-25000001